Repligen | Des Atouts



Assets Changement Date
Agilent USD 11.91B 68M 2025-01
Align Technology USD 6.21B 151.37M 2024-12
Bio Techne USD 2.67B 65.59M 2024-12
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Bruker USD 5.81B 302.5M 2024-12
Charles River Laboratories USD 7.53B 475.5M 2024-12
Danaher USD 77.54B 3.07B 2024-12
Dentsply International USD 5.75B 873M 2024-12
Exact Sciences USD 5.93B 820.43M 2024-12
General Electric USD 123.14B 3.56B 2024-12
Henry Schein USD 10.22B 387M 2024-12
Illumina USD 6.3B 289M 2024-12
IQVIA Holdings USD 26.9B 281M 2024-12
Mettler Toledo International USD 3.24B 79.83M 2024-12
Myriad Genetics USD 1.03B 53.7M 2024-12
Patterson Companies USD 2.83B 13.02M 2025-01
Pfizer USD 213.4B 6.08B 2024-12
Repligen USD 2.83B 31.28M 2024-09
Revvity USD 12.39B 377.26M 2024-12
Standard Biotools USD 612.34M 69.19M 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
Waters USD 4.55B 42.18M 2024-12
West Pharmaceutical Services USD 3.64B 31.7M 2024-12



Repligen Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.